Necrotising autoimmune myopathy: a differential diagnosis for deranged liver function tests

• 1 University of Sydney, Sydney, NSW
• 2 Royal Prince Alfred Hospital, Sydney, NSW
• 3 Canterbury Hospital, Sydney, NSW

---

• 1. Luu Q, Day J, Hall A, et al. External validation and evaluation of adding MRI or extended myositis antibody panel to the 2017 EULAR/ACR myositis classification criteria. ACR Open Rheumatol 2019; 1: 462‐468.
• 2. Pinal‐Fernandez I, Casal‐Dominguez M, Mammen AL. Immune‐mediated necrotizing myopathy. Current Rheumatol Rep 2018; 20: 21.
• 3. Suzuki S, Nishikawa A, Kuwana M, et al. Inflammatory myopathy with anti‐signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis 2015; 10: 61.
• 4. Liang C, Needham M. Necrotizing autoimmune myopathy. Curr Opin Rheumatol 2011; 23: 612‐619.
• 5. Aggarwal R, Oddis CV, Goudeau D, et al. Anti‐signal recognition particle autoantibody ELISA validation and clinical associations. Rheumatology 2015; 54: 1194‐1199.